UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comparative effectiveness of interventions for cancer treatment-related cognitive impairment in adult cancer survivors: protocol for a systematic review

Systematic reviews, 2024-08, Vol.13 (1), p.207-11, Article 207

2024

Volltextzugriff (PDF)

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

Neurology, 1999-09, Vol.53 (5), p.946-946

1999

Volltextzugriff (PDF)

The Use of Electroconvulsive Therapy in Special Patient Populations

Canadian journal of psychiatry, 2001-10, Vol.46 (8), p.710-719

Rabheru, Kiran

2001

Volltextzugriff (PDF)

Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?

The journal of ECT, 2012-03, Vol.28 (1), p.39-47

Rabheru, Kiran

2012

Volltextzugriff (PDF)

CAN A TRAINING MODULE USING VIRTUAL REALITY HELP ADDRESS RESPONSIVE BEHAVIOURS?

Innovation in aging, 2017-07, Vol.1 (suppl_1), p.1352-1352

2017

Volltextzugriff (PDF)

4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Canadian journal of neurological sciences, 2012-11, Vol.39 (S5), p.S1-S8

2012

Volltextzugriff (PDF)

Electroconvulsive therapy clinical database: a standardized approach in tertiary care psychiatry

The journal of ECT, 2010-12, Vol.26 (4), p.304-309

2010

Volltextzugriff (PDF)

Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease

International psychogeriatrics, 2002-12, Vol.14 (4), p.389-404

2002

Volltextzugriff (PDF)

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

International journal of geriatric psychiatry, 2005-06, Vol.20 (6), p.559-569

2005

Volltextzugriff (PDF)

A review of continuation and maintenance electroconvulsive therapy

Canadian journal of psychiatry, 1997-06, Vol.42 (5), p.476-484

1997

Volltextzugriff (PDF)

"No CPR" policy could be dangerous

Canadian family physician, 1997-04, Vol.43, p.609, 611, 613-613

Rabheru, K

1997

Volltextzugriff (PDF)

Four cases of progressive supranuclear palsy in patients exposed to organic solvents

Canadian journal of psychiatry, 1989-12, Vol.34 (9), p.934-936

1989

Volltextzugriff (PDF)

Response to ECT in depressed, demented patients; possible role of apolipoprotein E(4) as response marker

International journal of geriatric psychiatry, 2001-09, Vol.16 (9), p.919-920

2001

Volltextzugriff (PDF)

Response to ECT in depressed, demented patients; possible role of apolipoprotein E 4 as response marker

International journal of geriatric psychiatry, 2001-09, Vol.16 (9), p.919-920

2001

Volltextzugriff (PDF)

Hyperammonemia in Alzheimer's disease

The American journal of psychiatry, 1985-01, Vol.142 (1), p.71-73

1985

Volltextzugriff (PDF)

Risperidone for the treatment of behavioral disturbances in dementia: a case series

The journal of neuropsychiatry and clinical neurosciences, 1998, Vol.10 (2), p.220-223

1998

Volltextzugriff (PDF)

Apolipoprotein E Polymorphism and Response to Electroconvulsive Therapy

The Journal of ECT, 2001-03, Vol.17 (1), p.11-14

2001

Volltextzugriff (PDF)

Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjects

Archives of neurology (Chicago), 1990-11, Vol.47 (11), p.1185-1188

1990

Volltextzugriff (PDF)

Four cases of progressive supranuclear palsy in patients exposed to organic solvents

Canadian journal of psychiatry, 1989-12, Vol.34 (Dec 89), p.934-936

1989

Volltextzugriff (PDF)

2. Apolipoprotein E Polymorphism and Response to Electroconvulsive Therapy

The journal of ECT, 1999-03, Vol.15 (1), p.106

1999

Volltextzugriff (PDF)

Reaginic antibody production to Ascaris suum allergen, ASC-1. II. Influence of type of adjuvant and of carrier priming on the induction of IgE and IgG antibodies to dinitrophenyl conjugates

International archives of allergy and applied immunology, 1977, Vol.54 (6), p.502

1977

Volltextzugriff (PDF)

Reaginic Antibody Production to Ascaris suum Allergen, ASC-1

International archives of allergy and immunology, 1977-06, Vol.54 (6), p.502-516

1977

Volltextzugriff (PDF)

401 - Cannabis and Older Adults

International psychogeriatrics, 2021-10, Vol.33 (S1), p.28-29

2021

Volltextzugriff (PDF)

P3‐429: Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience

Alzheimer's & dementia, 2010-07, Vol.6 (4S_Part_19), p.S579-S579

2010

Volltextzugriff (PDF)

Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience

Alzheimer's & dementia, 2010-07, Vol.6 (4), p.S579-S579

2010

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Humans
(16)
Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Aged
(13)
Female
(11)
Biological And Medical Sciences
(10)
Male
(10)
Psychiatry
(10)
Medical Sciences
(9)
Psychology. Psychoanalysis. Psychiatry
(8)
Treatment Outcome
(8)
Electroconvulsive Therapy
(6)
Middle Aged
(6)
Psychopathology. Psychiatry
(6)
Aged, 80 And Over
(5)
Treatments
(5)
Clinical Neurology
(4)
Neurosciences & Neurology
(4)
Adolescent
(3)
Adult
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative effectiveness of interventions for cancer treatment-related cognitive impairment in adult cancer survivors: protocol for a systematic review

A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia

The Use of Electroconvulsive Therapy in Special Patient Populations

Maintenance electroconvulsive therapy (M-ECT) after acute response: examining the evidence for who, what, when, and how?

CAN A TRAINING MODULE USING VIRTUAL REALITY HELP ADDRESS RESPONSIVE BEHAVIOURS?

4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia

Electroconvulsive therapy clinical database: a standardized approach in tertiary care psychiatry

Efficacy of Donepezil on Behavioral Symptoms in Patients With Moderate to Severe Alzheimer's Disease

Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trial

A review of continuation and maintenance electroconvulsive therapy

"No CPR" policy could be dangerous

Four cases of progressive supranuclear palsy in patients exposed to organic solvents

Response to ECT in depressed, demented patients; possible role of apolipoprotein E(4) as response marker

Response to ECT in depressed, demented patients; possible role of apolipoprotein E 4 as response marker

Hyperammonemia in Alzheimer's disease

Risperidone for the treatment of behavioral disturbances in dementia: a case series

Apolipoprotein E Polymorphism and Response to Electroconvulsive Therapy

Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjects

Four cases of progressive supranuclear palsy in patients exposed to organic solvents

2. Apolipoprotein E Polymorphism and Response to Electroconvulsive Therapy

Reaginic antibody production to Ascaris suum allergen, ASC-1. II. Influence of type of adjuvant and of carrier priming on the induction of IgE and IgG antibodies to dinitrophenyl conjugates

Reaginic Antibody Production to Ascaris suum Allergen, ASC-1

401 - Cannabis and Older Adults

P3‐429: Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience

Response to cholinesterase inhibitor medication at first renewal in a Canadian provincial drug coverage initiative: the British Columbia Alzheimer's Drug Therapy Initiative (BC ADTI) experience

Suchergebnisse filtern